Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office (Steven Scheer/Reuters)
Steven Scheer / Reuters: Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office — Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Steven Scheer / Reuters:
Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office — Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.
